// COMPANY
Retro Biosciences
// OVERVIEW
Biotechnology company focused on aging and lifespan extension.
// RECENT MENTIONS
// SIGNALS
3 SIGNALS
01
funding·PostRound·JUNE 1, 2026
“Retro Biosciences raised $1 billion from Sam Altman. Described as a 'biotechnology company focused on aging and lifespan extension.'”
Source→02
mention·PostRound·JUNE 1, 2026
“The $1B Retro round is the single largest deal of the week and the dominant outlier skewing average deal size ($65.6M average vs. $16.7M median).”
Source→03
mention·PostRound·JUNE 1, 2026
“Retro Biosciences raised $1 billion from Sam Altman.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.